Chaga
Traditional use tradition
A charcoal-black growth that erupts from wounded birch trees in the coldest forests on earth, splits open to a rusty gold, and has been simmered into a daily tea across the north for centuries. Here's the honest version: chaga's chemistry is genuinely remarkable, its human evidence is genuinely thin, and its oxalate content is a real safety issue nobody should be glossing over. No hype - just what's known, what isn't, and how to use it well.
In one minute
Chaga isn't a normal mushroom. It's a hard black canker on living birch trees, and most of its mass is birch wood the fungus has colonised - not fungal tissue.
Health Canada permits exactly two things to be said about it: source of antioxidants, and source of fungal polysaccharides with immunomodulating properties. That's the whole permitted list.
Almost everything else you read about chaga comes from test tubes and rodents. Human clinical evidence is close to non-existent - Memorial Sloan Kettering states plainly that chaga's safety and effectiveness have yet to be evaluated in clinical studies.
Chaga is very high in soluble oxalates, and there are published case reports of serious kidney damage - including irreversible kidney failure - after months of heavy daily use.
It may slow blood clotting slightly and lower blood sugar, which matters if you take blood thinners or diabetes medication.
Wild chaga takes years to decades to form and is being over-harvested in accessible forests. Where yours came from is a real question, not a marketing one.
At a glance
History & natural history
Chaga's story is a northern one - a tree disease that became a household remedy across the boreal world.
What it actually is
Inonotus obliquus is a parasitic fungus that enters a birch through a wound and lives inside the trunk for years, sometimes decades. What appears on the outside is not a mushroom but a canker: a hard, cracked, charcoal-black mass that splits to reveal a rusty amber interior. Chemical analysis suggests as little as ten percent of that mass is fungal mycelium - the rest is birch wood the fungus has grown through and transformed. The fungus doesn't produce a true fruiting body until well after the host tree has died, sometimes ten to eighty years after the original infection.
The folk tradition
Across Siberia, the Russian north, Finland, the Baltic states and the Canadian and Alaskan boreal, chaga was chipped from birch trunks, dried, ground and simmered into a dark daily tea. It was a winter drink - taken for stamina and general resilience through long, hard seasons - and in periods of shortage it doubled as a coffee substitute. Indigenous peoples of the northern forests, including Cree and Ojibwe communities in Canada, also used the burning conk as a slow-smouldering tinder for carrying fire, and in some traditions for smudging. It is one of the most geographically widespread folk remedies in the circumboreal world, which is part of what makes the tradition credible even where the science isn't.
How it reached the West
Chaga's Western fame has a specific literary source. Alexander Solzhenitsyn's 1968 novel Cancer Ward featured a rural Russian doctor treating patients with birch fungus tea, and the passage did more to build chaga's reputation abroad than any study before or since. Soviet-era research on chaga - and the registration of a chaga preparation called Befungin - gave the story an official-sounding backing that has been widely over-interpreted ever since.
The modern chapter
Interest in chaga climbed sharply through the 2010s and again after 2020. It became the single most-searched item on Memorial Sloan Kettering's About Herbs database in 2018. That popularity has had two consequences worth knowing: wild reserves in accessible forests have come under real pressure, prompting research into cultivated substitutes; and a series of case reports emerged in the medical literature - Japan in 2014, Korea in 2020 and 2022 - documenting kidney damage in people taking large daily doses of chaga powder for months. Both belong in an honest history of this mushroom, alongside the birch trees and the winter tea.
The science, graded honestly
We grade the evidence for every use so you can see the difference between "proven," "promising," and "traditional."
Chaga is chemically unusual, and understanding why explains most of the confusion around it.
## It's a canker, not a mushroom cap
When Inonotus obliquus infects a birch, the tree responds by forming a black, charcoal-like growth called a conk or canker. Chemical analysis suggests that as little as ten percent of that mass is fungal mycelium - the rest is birch wood the fungus has grown through and transformed. This matters more than it sounds. Several of chaga's most-marketed compounds, including betulin and betulinic acid, come from the birch tree, not the fungus. Lab-grown chaga mycelium, which never touches a birch, largely lacks them.
## The main compound groups
- Melanin. The black exterior is loaded with fungal melanin, a dark pigment that soaks up free radicals in a test tube. This is the source of chaga's dramatic antioxidant numbers.
- Polyphenols and small phenolic acids. Gallic acid, protocatechuic acid and p-hydroxybenzoic acid are all present. In Cui and colleagues' 2005 work, the polyphenol-rich fraction was the one carrying most of the antioxidant activity in the dish.
- Triterpenes and sterols. Inotodiol, ergosterol peroxide, lanostane-type triterpenes. These are the compounds most often studied for effects on cells, and they are alcohol-soluble, not water-soluble.
- Beta-glucans and other fungal polysaccharides. These are the basis of Health Canada's permitted immunomodulating statement. They are water-soluble and need heat to be released.
- Oxalic acid. Present at levels far above ordinary edible mushrooms. This is a genuine safety consideration, not a footnote - see the practitioner note below.
## The proposed mechanisms
In cell and animal studies, chaga extracts have been reported to mop up free radicals, dampen inflammatory signalling through iNOS and COX-2, shift the balance of Th1 and Th2 immune signalling, and inhibit alpha-glucosidase, an enzyme involved in digesting carbohydrates. Every one of those is a plausible mechanism. None of them has been demonstrated to produce a measurable health outcome in a properly controlled human trial.
## Why extraction method changes what you get
Because the actives split across two solubility classes, no single extraction captures everything. Hot water pulls out the beta-glucans and polysaccharides - the traditional Siberian decoction, and the basis of the permitted immune wording. Alcohol pulls out the triterpenes, sterols and betulinic acid. A dual extract does both and then recombines them. Traditional tea is not wrong; it's simply a partial extraction of a chemically complicated raw material.
Antioxidant
Emerging but limitedThis is chaga's strongest card and it still needs careful handling.
The laboratory work is genuinely impressive. In a 2005 study by Cui, Kim and Park in the Journal of Ethnopharmacology, researchers took four different extracts of chaga and tested each against three separate free-radical assays - DPPH, superoxide and peroxyl radicals. The polyphenol-rich extract showed strong activity across the board, the triterpene-and-sterol extract showed moderate activity, and, notably, the polysaccharide extract showed essentially none. That last detail is useful: it tells you chaga's antioxidant power sits in its phenolic and pigment fractions, not in its beta-glucans. Later chemical work by Glamoclija and colleagues in 2015 confirmed the phenolic line-up - gallic, protocatechuic and p-hydroxybenzoic acids - and showed the profile varies substantially depending on where the chaga grew.
The closest thing to human evidence is a 2007 study by Najafzadeh and colleagues, and it's important to describe it accurately because it is often mis-reported. Researchers took blood from patients with inflammatory bowel disease and from healthy volunteers, isolated the white blood cells, and treated those cells in a dish with chaga extract before exposing them to an oxidising agent. The chaga-treated cells showed less DNA damage. That is a real result, but it is an ex-vivo experiment on cells in a laboratory - the patients themselves never took chaga, and nothing about their symptoms, inflammation or disease course was measured.
What Health Canada permits is a compositional statement, not an outcome: chaga may be described as a source of antioxidants. That means the material contains antioxidant compounds. It does not mean, and Health Canada is not saying, that taking it produces a specific health benefit. We think that distinction is worth understanding, because most marketing quietly collapses it.
The honest grade: strong in vitro, plausible, no human outcome data.
Cui 2005, J Ethnopharmacol 96(1-2):79-85 ↗Immune support
Emerging but limitedImmune support is the claim Health Canada actually permits for chaga, so it deserves a clear-eyed look at what's behind it.
The permitted wording - source of fungal polysaccharides with immunomodulating properties - rests on a broad body of work on mushroom beta-glucans generally, not on chaga trials specifically. The mechanism is well described: beta-glucans bind to pattern-recognition receptors such as Dectin-1 on macrophages and dendritic cells, which changes cytokine output. It's why this class of compound is taken seriously at all.
The chaga-specific evidence is animal work. In a 2011 study by Ko, Jin and Pyo in the Journal of Ethnopharmacology, mice were sensitised to egg protein - a standard way of provoking an allergic immune response - and then given chaga extract. The treated mice produced less antigen-specific IgE, and the balance of their Th1 and Th2 cytokine signalling shifted. In a separate 2013 mouse study, chaga extract reduced anaphylactic shock triggered chemically. Other rodent work found anti-inflammatory effects in chemically induced colitis, with reduced TNF-alpha, iNOS and IL-1beta.
Every one of those is a mouse. None of it is a person. Memorial Sloan Kettering, reviewing the same literature, concludes flatly that the safety and efficacy of chaga have yet to be evaluated in clinical studies. Michael Beug of the North American Mycological Association's toxicology committee makes the sharper point: there is little correlation between petri-dish results, successful animal studies and successful human studies, and without human clinical work you cannot conclude a mushroom is truly medicinal.
One further caution that follows from the mechanism rather than from any trial: if immune signalling really is being modulated, people with autoimmune conditions or on immunosuppressant medication should be talking to their prescriber before adding it. That's a precaution, not a documented problem.
The honest grade: a permitted claim with a plausible mechanism and animal support, and no human outcome data behind it.
Ko 2011, J Ethnopharmacol 137(3):1077-1082 ↗Blood sugar
Emerging but limitedThis area matters less as a reason to take chaga and more as a reason to be careful with it.
The in-vitro finding is specific. In 2014, Ying and colleagues, publishing in Phytochemistry, isolated terpenoids from submerged-culture chaga and tested them against alpha-glucosidase. Alpha-glucosidase is the intestinal enzyme that chops complex carbohydrates into glucose you can absorb - it's the same target as the diabetes drug acarbose. Several chaga terpenoids inhibited it in the test tube.
The animal work runs in the same direction. Wang and colleagues, in PLoS One in 2017, gave polysaccharides isolated from chaga to mice made diabetic with streptozotocin and reported improved glucose measures alongside reduced markers of oxidative stress. Earlier work by Sun and colleagues in 2008 found antihyperglycaemic effects in both normal and chemically diabetic mice using dry matter from chaga culture broth. Consistent, repeated, and entirely rodent.
There is no human trial. Not a small one, not a pilot. Memorial Sloan Kettering lists hypoglycaemic agents under herb-drug interactions specifically because of these preclinical findings, noting that chaga had additive blood-sugar-lowering effects in vitro and that the clinical significance is yet unknown.
So here is the practical reading, which we'd rather give you than a benefit story. If you are not on diabetes medication, treat this as an interesting mechanism with no demonstrated effect in people - don't take chaga for your blood sugar. If you are on metformin, a sulfonylurea, insulin or anything else that lowers glucose, treat it as a possible additive effect and talk to your prescriber before starting. The absence of human data cuts both ways: it means we can't promise a benefit, and it also means we can't rule out an interaction.
The honest grade: preclinical only, and more useful as a caution than as a claim.
Ying 2014, Phytochemistry 108:171-176; Wang 2017, PLoS One ↗Stamina & resilience
Traditional useThis is chaga's oldest use and, in a sense, its most defensible one - as long as nobody dresses it up as science.
The tradition is well documented. Across Siberia and Northern Europe, chaga was chipped from birch trunks, ground, and simmered into a dark daily tea, drunk through winter for general stamina and resilience. In parts of Russia it also served as a coffee substitute during shortages. This is folk practice with real historical depth, not invented heritage - and it is what Health Canada, in listing chaga among traditional mushroom preparations, is implicitly acknowledging.
The modern supporting research is thin and animal-only. In 2015, Yue and colleagues gave polysaccharides isolated from chaga to mice and then ran standard fatigue tests. The treated mice swam longer, had more glycogen stored in liver and muscle, and had lower blood lactic acid and serum urea nitrogen afterwards. That is a textbook antifatigue result - in mice, using an isolated polysaccharide fraction, at doses that don't map cleanly onto a human cup of tea. There is no equivalent study in people.
One related area is worth mentioning honestly: a 2011 rodent study by Giridharan and colleagues found that a methanol extract of chaga improved learning and memory measures in mice whose cognition had been chemically impaired, alongside changes in oxidative-stress markers and acetylcholine levels. That result circulates online as evidence chaga is good for the brain. It is one mouse study using an induced-deficit model, and it should not be read as a cognitive claim for humans.
The honest grade: a real tradition, a plausible ritual benefit, and no human evidence that it does anything measurable for energy or stamina. If you drink it because it's warm, dark and grounding on a February morning, that's a perfectly good reason - and we'd rather you had that reason than a fake one.
Yue 2015, J Tradit Chin Med 35(4):468-472 ↗Skin & aging
Traditional useChaga shows up constantly in beauty marketing, usually alongside the word melanin. It's worth separating what's true from what's implied.
What's true: chaga's black exterior really is heavily melanised, and fungal melanin really is a capable antioxidant in laboratory testing. Chaga extracts really do score highly on free-radical scavenging assays, as Cui and colleagues showed in 2005. Antioxidant activity and skin aging really are biologically connected, since ultraviolet light and oxidative stress contribute to collagen breakdown over time.
What's implied but not shown: that drinking chaga, or putting it on your face, produces a visible change in skin. There is no clinical trial. There is no controlled study measuring wrinkle depth, elasticity, hydration, pigmentation or any other standard dermatological endpoint after chaga use. Memorial Sloan Kettering's list of purported uses for chaga is short - inflammation, liver protection, immune stimulation - and skin is not on it. The one dermatology-adjacent appearance chaga makes in the clinical literature is sobering rather than encouraging: a 49-year-old man who had been taking chaga long-term for atopic dermatitis developed end-stage renal disease.
There is also a specific ingredient point people get wrong. Betulinic acid, frequently cited in chaga skincare copy, comes from the birch tree the fungus grows on, not from the fungus itself. Cultivated chaga mycelium, which is increasingly what's in commercial products, largely lacks it.
We've graded this as traditional use rather than emerging, because even the preclinical work here is mostly about antioxidant chemistry in general rather than about skin specifically. The mechanism is a reasonable hypothesis. It is not a finding.
The honest grade: a plausible story built on antioxidant chemistry, with no skin-specific research in people or, really, in animals.
MSK About Herbs, Chaga Mushroom ↗Cancer claims
PreliminaryWe are including this claim specifically to say no to it, because it is the single most common thing said about chaga online and the most dangerous thing to get wrong.
The folk reputation is real. Chaga was used in Russia and Northern Europe as a remedy for a wide range of ailments including cancer, and Alexander Solzhenitsyn's novel Cancer Ward gave that reputation enormous reach in the West. Memorial Sloan Kettering records this history plainly in its clinical summary.
The laboratory work is also real, and it is extensive. Water extracts of chaga triggered cell-cycle arrest and apoptosis in human liver cancer cells in a dish. Ergosterol peroxide from chaga suppressed colorectal cancer cells by downregulating the beta-catenin pathway. Inotodiol, one of chaga's triterpenes, inhibited proliferation in cervical cancer cells. Chaga extract inhibited melanoma growth in mice. Cytotoxic constituents induced apoptosis in human lung adenocarcinoma cells.
Here is what that does and does not mean. A compound killing cancer cells in a dish is the very first step in a pipeline where the overwhelming majority of candidates fail. The gap between a petri dish and a person is where almost all promising cancer compounds die, and chaga has not taken a single step across it. There is not one controlled human trial of chaga in cancer. Memorial Sloan Kettering's summary is explicit: the safety and efficacy of chaga have yet to be evaluated in clinical studies.
And there is a specific harm here, not just an absence of benefit. In one of the published oxalate nephropathy cases, the patient was a woman with liver cancer taking heavy daily doses of chaga powder; she lost her kidney function permanently. Another case involved a man with atopic dermatitis who reached end-stage renal disease. People taking chaga in hope, at high doses, for serious illness are exactly the people the kidney case reports describe.
If you have cancer: tell your oncology team about any supplement you're considering, including this one. Chaga is not a treatment, and nothing on this page should be read as suggesting otherwise.
The honest grade: preliminary laboratory science only, and not a human health claim in any form.
MSK About Herbs, Chaga Mushroom; Kikuchi 2014, Clin Nephrol ↗Who chaga suits - and who should leave it alone
It may suit you if
You like the ritual. Chaga's oldest and most honest use is as a daily brew - a dark, earthy, faintly vanilla-scented drink that people across Siberia and Northern Europe have made for generations. If you enjoy that, and you go in with modest expectations, it's a pleasant addition to a routine.
You want a general antioxidant and immune-adjacent botanical and you're comfortable with the evidence being thin. Health Canada's two permitted statements are real, and they're the honest ceiling of what can be said.
You're already drinking coffee or tea and want something with a bit more depth and no caffeine.
You use it in moderation - occasional or modest daily amounts, not heaped spoonfuls of concentrated powder every day for months.
It probably isn't for you if
You have kidney disease, reduced kidney function, or a history of kidney stones. This is the clearest contraindication on the page. Chaga's soluble oxalate load is high enough that it has caused documented kidney injury.
You take blood thinners or antiplatelet drugs, or you have surgery coming up. A platelet-aggregation-inhibiting peptide has been isolated from chaga, and MSK specifically flags a possible increased bleeding risk with warfarin.
You take medication for diabetes. Chaga has shown blood-sugar-lowering effects in animals and enzyme-inhibiting effects in vitro; stacking it with glucose-lowering drugs without supervision isn't sensible.
You're pregnant or breastfeeding. Health Canada requires a practitioner-consultation statement here, and there simply isn't safety data.
You take high-dose vitamin C. In one published case, a man taking chaga powder alongside 500 mg of vitamin C daily developed acute kidney injury - vitamin C is itself metabolised to oxalate, so the two stack.
You're expecting a dramatic, noticeable effect. Chaga is not a stimulant, not a nootropic, and not something you feel.
Chaga next to the other functional mushrooms
If you're choosing between mushrooms, it helps to be blunt about where chaga sits.
On evidence
Chaga has less human evidence than almost any of its shelf-mates. Reishi has small human trials. Lion's Mane has several, including a 16-week randomised study in older adults. Turkey tail's PSK fraction has decades of clinical use in Japan. Cordyceps has small exercise trials. Chaga has essentially none of that - the enthusiasm is built on cell cultures and mice. Michael Beug, chair of the North American Mycological Association's toxicology committee, put it directly: there is too little evidence to say whether taking chaga is healthy for humans.
On safety
This is the bigger differentiator. Lion's Mane, reishi and turkey tail have quiet safety records. Chaga has published case reports of oxalate nephropathy and end-stage renal disease. That doesn't make it dangerous at sensible doses - it makes it the one on the shelf where dose and duration genuinely matter.
On what it's for
Chaga - antioxidant and immune-adjacent, a daily brew, traditionally a winter tonic.
Reishi - the calming one; sleep, stress and immune support in traditional use.
Lion's Mane - the cognitive one, with the most credible human research behind it.
Cordyceps - the energy and endurance one.
Turkey tail - the most researched immune mushroom, largely as a standardised extract in oncology settings.
On sourcing
Chaga is the only one of the group that is meaningfully wild-harvested at commercial scale. Lion's Mane, reishi, cordyceps and turkey tail are all farmed. That gives chaga a sustainability problem the others don't have.
Practical note
Because chaga is mild, non-stimulating and pleasant to drink, it stacks easily with others in a blend. If you want one mushroom to do real work, though, chaga would not be our first recommendation - and we'd rather say that than sell you a story.
Where chaga comes from - and why it's running out
Chaga is the slowest thing on the functional mushroom shelf, and that's the root of the problem.
It takes years, not weeks
A chaga canker forms after the fungus infects a wounded birch, then grows outward slowly - commonly cited at five to ten years to reach a harvestable size, and the fungus may not fruit properly until a decade or more after the tree dies. There is no quick regrowth. When a conk is cut off a tree, that tree does not replace it on any human timescale.
Wild reserves are under real pressure
Memorial Sloan Kettering notes that natural reserves of the fungus have nearly been exhausted, which is precisely why researchers are working on cultivated substitutes. Chaga is not IUCN-listed as endangered, and we won't overstate it - but demand has climbed sharply and accessible boreal forests in Northern Europe and North America are being picked over. The honest summary is: not endangered, definitely not unlimited.
Wild versus cultivated is a genuine trade-off
This isn't a case where the farmed version is simply as good. Cultivated chaga mycelium, grown on grain or in liquid culture, never grows through birch - so it lacks betulin, betulinic acid and the birch-derived phytosterols that people specifically want from chaga. Beug notes you would expect a different suite of effects from cultivated chaga because the chemistry is different. Cultivated material solves the sustainability problem and changes the product.
What responsible harvesting looks like
Take only from living birch. Cankers on dead trees are inactive.
Never take the whole conk. A widely used field rule is to leave the majority behind - commonly no more than about a third removed - and leave the base attached so it can continue growing.
Leave small conks alone entirely.
Harvest in winter, when the material is dry and easier to remove cleanly without damaging the tree further.
What to ask a seller
Where was it harvested, from living or dead birch, and is any of it cultivated mycelium rather than wild canker? A brand that can't answer those questions hasn't asked them either.
Practitioner note: oxalates, kidneys, and dose
This is the part of the chaga story that gets skipped, and it shouldn't be.
The oxalate problem is real and measured
Chaga contains far more oxalate than ordinary mushrooms - and crucially, most of it is the soluble kind that actually gets absorbed. In Glamoclija and colleagues' 2015 chemical analysis, Russian chaga measured around 3,904 mg of soluble oxalate per kg of dry material and Finnish material around 5,340 mg/kg. For scale, the cultivated and wild edible mushrooms measured in earlier surveys ran in the hundreds of mg/kg total, and in several species almost all of it was the insoluble, harmlessly excreted form. Chaga sits in the same oxalate bracket as almonds, cereal grains and chocolate - well below spinach or rhubarb, but far above any other mushroom you'd put in a supplement.
Three published cases of kidney damage
These are not hypothetical.
A 72-year-old Japanese woman with liver cancer took 4 to 5 teaspoons of chaga powder daily for six months. Biopsy showed oxalate crystals in the kidney tubules. She required haemodialysis and her kidney function did not recover.
A 49-year-old Korean man using chaga long-term for atopic dermatitis developed end-stage renal disease with oxalate crystal deposits on biopsy. He also required dialysis without recovery.
A 69-year-old Korean man taking 10 to 15 g of chaga powder daily alongside 500 mg of vitamin C for three months developed acute kidney injury presenting as nephrotic syndrome. He recovered after dialysis and high-dose steroids.
The pattern in all three: concentrated powder, high daily amounts, sustained for months. The British Columbia poison centre has also recorded a handful of chaga-related cases since 2010, including two involving treated liver and kidney damage.
What that means practically
Health Canada caps chaga at 3.6 g of dried material per day. Two of the three case-report patients were well above that. Treat the cap as a real limit, not a formality.
Screen for kidney history before recommending it - stones, reduced eGFR, any nephropathy.
Watch the vitamin C stack. Ascorbic acid is metabolised to oxalate; high-dose vitamin C plus daily chaga powder is the exact combination in one of the case reports.
Traditional tea is the lower-oxalate route. A brewed cup delivers a modest fraction of what a heaped spoon of concentrated powder does.
Hydration matters, as with any oxalate load.
The other two cautions
A platelet-aggregation-inhibiting peptide has been isolated from chaga, and MSK advises talking to a prescriber before combining chaga with warfarin or similar anticoagulants. Separately, chaga triterpenes inhibit alpha-glucosidase in vitro and chaga polysaccharides lowered blood glucose in diabetic mice - so additive effects with hypoglycaemic drugs are plausible, though clinical significance is unknown. Neither of these is proven in people. Both are worth respecting.
— Kikuchi 2014; Lee 2020; Kwon 2022; Glamoclija 2015
What we're actually allowed to say
Myth or fact?
Tap each one to see the verdict.
Chaga really does post enormous numbers on antioxidant assays - its melanin and polyphenols are genuinely potent free-radical scavengers in a test tube, as Cui and colleagues demonstrated in 2005. The problem is what those numbers mean. ORAC measures how a substance behaves in a laboratory tube, not in your body. The USDA thought this was misleading enough that in May 2012 it withdrew its own ORAC database entirely, stating that the values have no relevance to the effects of specific bioactive compounds, that in-vitro antioxidant data cannot be extrapolated to effects in the body, and that the numbers were being routinely misused to market foods and supplements. On top of that, chaga is not a food you eat by the bowl - you drink a small amount of extract, so the per-100-gram figure is doing a lot of unearned work. True that the assay number is high; not true that this makes chaga the most powerful antioxidant food you can consume. NutraIngredients: USDA removes ORAC database (2012) ↗
The folk history is genuine and the laboratory findings are genuine, but neither proves anything about people. Chaga extracts have induced apoptosis in liver, colon, lung and cervical cancer cell lines in dishes, and slowed melanoma in mice. Not one controlled human trial exists. Memorial Sloan Kettering, which maintains one of the most carefully referenced supplement databases in oncology, states directly that the safety and efficacy of chaga have yet to be evaluated in clinical studies. The stakes here are not abstract: in the published oxalate nephropathy case reports, the patients using chaga heavily were people with serious illness hoping it would help, and two of the three ended up on permanent dialysis. If you have cancer, chaga is a conversation to have with your oncology team - not a treatment. MSK About Herbs, Chaga Mushroom ↗
Two things are wrong with this. First, chemistry: chaga's cell walls are chitin, and its beta-glucans and polysaccharides are locked behind them. Without prolonged hot-water extraction you get very little of what you're after - which is exactly why the traditional preparation everywhere chaga is used is a long simmered decoction, not raw material. Second, and more seriously, dose. Raw powder is where the oxalate cases come from. The 72-year-old woman in the 2014 Japanese case report was taking 4 to 5 teaspoons of powder a day; the 2022 Korean case involved 10 to 15 grams a day. Health Canada caps chaga at 3.6 grams of dried material per day, which is well under a couple of teaspoons. Chaga is not a food you scale up. Brew it, and stay inside the limit. Kikuchi 2014, Clin Nephrol 81(6):440-444 ↗
It does not just grow back, at least not on any timescale that helps. A chaga canker commonly takes five to ten years to reach harvestable size after the fungus infects a wounded birch, and the fungus may not fruit until a decade or more after the host tree dies. Memorial Sloan Kettering notes that natural reserves of chaga have nearly been exhausted, which is precisely why scientists have been working on cultivated substitutes. Chaga is not formally listed as endangered and we won't overstate the case - but demand has risen sharply and accessible boreal forests are being worked hard. Responsible harvest means taking only a portion of a conk from a living birch and leaving the base to regrow, and it means asking your supplier where the material came from. MSK About Herbs, Chaga Mushroom ↗
Chaga is caused by a fungus, but the black conk you buy is not a mushroom in the usual sense. It's a sterile canker: a mass of birch wood that the fungus Inonotus obliquus has grown through and chemically transformed. Analysis suggests as little as about ten percent of it is fungal mycelium - the rest is tree. The fungus doesn't produce a true fruiting body until well after the host birch dies. This has two practical consequences. First, several of chaga's headline compounds - betulin, betulinic acid, birch phytosterols - come from the tree, not the fungus, so lab-cultivated chaga mycelium is chemically a different product. Second, chaga's very high soluble oxalate content is unlike any other functional mushroom on the shelf, which is why it carries kidney cautions that reishi and lion's mane don't. Beug, NAMA Toxicology Committee; Glamoclija 2015, J Ethnopharmacol ↗
How to use it
Common forms
How much
Health Canada sets a firm ceiling of 3.6 g of dried chaga material per day - and the same limit applies to aqueous extracts, standardised or not. In practice that's roughly 1/2 to 1 tsp of powder, or a small handful of chunks simmered into a pot of tea across a day. Concentrated extracts are dosed lower; follow the label, since an 8:1 extract is not interchangeable gram-for-gram with raw powder. Unlike most supplements, this ceiling exists for a concrete reason: the published kidney injury cases all involved 4-5 tsp or 10-15 g per day, sustained for months - three to five times the Canadian limit. Timing is flexible (no caffeine, no stimulant), and drinking water alongside it is sensible given the oxalate load. Chaga is not a supplement where more is better.
1/2 to 1 tsp in hot water, coffee or tea.
Five things worth checking before you buy chaga - more than most mushrooms, because more can go wrong:
Extraction, not raw powder. Chaga's chitin cell walls mean unextracted powder gives you very little. Look for hot-water or dual extraction, and a stated extract ratio.
Beta-glucans, not just 'polysaccharides.' A bare polysaccharide number can be padded with starch from a grain substrate.
Wild birch canker or cultivated mycelium - and which one you're getting. Cultivated chaga is more sustainable but lacks the birch-derived betulinic acid and phytosterols that people buy chaga for. Neither is wrong; a brand that won't tell you is.
Third-party heavy metal testing. Chaga spends a decade concentrating whatever is in its tree and soil. This one isn't optional.
A dose you can actually count. The label should let you work out grams per serving so you can stay under Health Canada's 3.6 g/day ceiling. If it only lists capsules, do the maths before you start.
Frequently asked questions
Straight answers to the things people actually ask.
Chaga (Inonotus obliquus) is a fungus that infects birch trees in cold northern forests - Siberia, Scandinavia, Northern Europe and the Canadian and Alaskan boreal. What you buy isn't a mushroom cap. It's the conk or canker: a hard, cracked, charcoal-black growth that erupts from the trunk, with a rusty-gold interior. Chemically it's a hybrid - analysis suggests as little as about ten percent is fungal mycelium and the rest is birch wood the fungus has grown through and transformed. It has been brewed as a daily tea across the north for centuries. In Canada, Health Canada permits it to be described as a source of antioxidants and a source of fungal polysaccharides with immunomodulating properties. It is not psychoactive and it contains no caffeine.
Honestly? Less than the internet says, and we'd rather tell you that up front. What can be said in Canada is narrow and specific: chaga is a source of antioxidants, and a source of fungal polysaccharides with immunomodulating properties. Those are compositional statements about what's in it.
Everything else - the antitumour, antiviral, antidiabetic, anti-inflammatory and cognition findings you'll read about - comes from cells in dishes and from rodents. Memorial Sloan Kettering's clinical summary puts it plainly: the safety and efficacy of chaga have yet to be evaluated in clinical studies. There is no meaningful body of human trial evidence for chaga doing anything.
What it reliably is: a pleasant, earthy, caffeine-free daily brew with a long tradition behind it and a genuinely rich antioxidant chemistry. If that's what you want, it delivers. If you're expecting to feel something, you probably won't.
Because chaga's active compounds don't all dissolve in the same thing, and raw powder gives you very little of any of them.
Chaga's cell walls are chitin - tough, indigestible, and effective at locking its contents away. Extraction breaks them open.
Hot water extraction pulls out the beta-glucans and other fungal polysaccharides. This is the traditional decoction - chunks simmered for hours - and it's the basis of Health Canada's permitted immunomodulating wording.
Alcohol extraction pulls out the triterpenes and sterols - inotodiol, ergosterol peroxide, lanostanes - plus the birch-derived betulinic acid. These are alcohol-soluble and hot water largely leaves them behind.
A dual extract does both separately and recombines them, so you get both fractions. It's the most complete option and generally the most expensive.
One useful nuance: Cui and colleagues found in 2005 that chaga's antioxidant activity sat mainly in the polyphenol and triterpene fractions, and that the polysaccharide fraction had essentially none. So if antioxidants are your interest, water alone isn't the whole picture. If it's the permitted polysaccharide claim you care about, hot water is exactly right.
One more practical point: the traditional hot-water tea also delivers a smaller oxalate load than spooning concentrated powder, which matters given chaga's kidney cautions.
Health Canada sets a clear ceiling: no more than 3.6 grams of dried chaga material per day - and the same 3.6 g limit applies to standardised and non-standardised aqueous extracts. That is the number to work to, and unlike most supplement limits it exists for a real reason.
In practice that's roughly half a teaspoon to a teaspoon of powder, or a small handful of chunks simmered into a pot of tea over a day. Concentrated extracts are dosed lower - follow the label, because an 8:1 extract at 3.6 g is not the same as raw powder at 3.6 g.
The reason to respect the cap: in the published kidney injury case reports, patients were taking 4 to 5 teaspoons a day, or 10 to 15 grams a day, sustained for months. Those doses are three to five times the Canadian limit. Chaga is not a supplement where more is better, and it is emphatically not one to megadose.
Timing is flexible - no stimulant, so morning or evening both work. Drink water alongside it, as you would with any oxalate-containing food.
You may well not notice anything, and we think it's more useful to say that than to give you a timeline that sets you up for disappointment.
Chaga has no acute effect. It isn't a stimulant, it doesn't cross into anything you'd feel, and there is no human trial establishing a time-to-effect for any outcome - because there is no human trial establishing an effect at all. Any 'give it 4 to 6 weeks' advice you read about chaga is extrapolated from other mushrooms, not measured for this one.
What we'd suggest instead: treat chaga as a daily ritual rather than an intervention. Drink it because you like it, keep it within Health Canada's 3.6 g/day limit, and don't hold it to a standard the evidence can't support. If after a few months it's just a nice cup of tea to you, that's the accurate outcome - not a failure.
This is the most important question on the page, and the answer is: it can be, at high doses over long periods.
Chaga is very high in oxalate, and unusually, most of it is the soluble kind that your body actually absorbs. Chemical analysis published in 2015 measured roughly 3,904 mg of soluble oxalate per kg of dry material in Russian chaga and about 5,340 mg/kg in Finnish material. Ordinary edible mushrooms measure in the hundreds of mg/kg, and in many species almost all of it is the insoluble form that passes straight through. Chaga sits alongside almonds, cereal grains and chocolate as a high-oxalate food - below spinach and rhubarb, but far above anything else on a mushroom shelf.
Absorbed oxalate binds calcium and can crystallise in the kidney tubules. Three published case reports document exactly that:
- A 72-year-old woman taking 4 to 5 teaspoons of chaga powder daily for six months developed oxalate nephropathy. She needed dialysis and her kidney function never recovered.
- A 49-year-old man using chaga long-term developed end-stage renal disease with oxalate crystals on biopsy. Also permanent.
- A 69-year-old man taking 10 to 15 g daily plus 500 mg of vitamin C for three months developed acute kidney injury. He recovered after dialysis and steroids.
What this means for you: at Health Canada's limit of 3.6 g per day, with normal kidney function and reasonable hydration, chaga is not a known hazard. The cases all involved several times that dose, sustained for months. But if you have kidney disease, reduced kidney function, or a history of kidney stones, skip chaga entirely - the risk isn't worth a benefit this unproven. And don't stack it with high-dose vitamin C, which your body also converts to oxalate.
A longer list than for most functional mushrooms, which is itself worth knowing.
- Anyone with kidney disease, reduced kidney function, or a history of kidney stones. This is the firm one. Chaga's soluble oxalate load has caused documented, sometimes irreversible kidney injury.
- Anyone taking blood thinners or antiplatelet drugs - warfarin, clopidogrel, daily aspirin. A platelet-aggregation-inhibiting peptide has been isolated from chaga, and Memorial Sloan Kettering specifically advises talking to your provider because chaga may increase bleeding risk.
- Anyone with surgery coming up. Pause it well beforehand for the same reason, and discuss with your surgical team.
- Anyone on diabetes medication. Chaga has lowered blood glucose in animal studies and inhibits a carbohydrate-digesting enzyme in vitro. Additive effects with metformin, sulfonylureas or insulin are plausible.
- Anyone pregnant or breastfeeding. Health Canada requires a practitioner-consultation statement, and there's no safety data.
- Anyone taking high-dose vitamin C alongside it.
- Anyone with an autoimmune condition or on immunosuppressants should raise it with their prescriber first, given chaga's immunomodulating polysaccharides. This is a precaution based on mechanism, not a documented problem.
- And of course, anyone with a mushroom allergy.
One more: if you're unwell and hoping chaga will treat it, please talk to your medical team. The people in the kidney case reports were doing exactly that.
Two documented interaction concerns, both flagged by Memorial Sloan Kettering, and both based on preclinical evidence rather than human studies - which means they're plausible rather than proven.
Blood thinners and antiplatelet drugs. A peptide isolated from chaga inhibited platelet aggregation in a mouse model, and chaga extract has shown antiplatelet activity. MSK advises talking to your healthcare provider if you take warfarin or similar anticoagulants, because chaga may increase bleeding risk. Combined effects are possible but the clinical relevance is unknown.
Blood-sugar-lowering medications. Chaga terpenoids inhibit alpha-glucosidase in vitro - the same enzyme target as acarbose - and chaga polysaccharides lowered glucose in diabetic mice. MSK notes additive blood-sugar-lowering effects in vitro, with clinical significance yet unknown.
A third, non-drug interaction worth taking seriously: high-dose vitamin C. Your body metabolises ascorbic acid to oxalate, and chaga is already high in oxalate. One published case of acute kidney injury involved exactly this combination.
And a general principle: if you take any prescription medication, tell your pharmacist or doctor you're taking chaga. The evidence base is thin enough that unknown interactions are entirely possible.
Sourcing matters more for chaga than for any other functional mushroom, for two separate reasons.
Sustainability. Chaga is the only major functional mushroom still harvested from the wild at commercial scale - reishi, lion's mane, cordyceps and turkey tail are all farmed. And it is slow: a canker commonly takes five to ten years to reach harvestable size, and the fungus may not fruit until a decade or more after the host birch dies. Memorial Sloan Kettering notes that natural reserves have nearly been exhausted, which is why researchers are working on cultivated substitutes. Chaga isn't formally endangered, but accessible boreal forests are under real pressure. Responsible harvesting means taking only part of a conk from a living birch and leaving the base to keep growing.
Chemistry. Wild and cultivated chaga are not the same product. Cultivated mycelium grown on grain or in liquid culture never grows through a birch tree, so it lacks betulin, betulinic acid and birch phytosterols - some of the very compounds people buy chaga for. Cultivated material is kinder to the forest and chemically different. Neither option is simply better; you should just know which one you have.
What to ask a supplier: Where was it harvested? From living or dead birch - cankers on dead trees are inactive. Is it wild canker or cultivated mycelium? Is it third-party tested for heavy metals? Chaga concentrates what's in its environment, so testing is not optional.
Side effects & safety
- Oxalates & kidney health: The most important caution on this page. Chaga is very high in soluble oxalate - roughly 3,900-5,300 mg/kg of dry material, far above any other functional mushroom. Three published case reports document oxalate nephropathy or end-stage renal disease after months of heavy daily use, two of them irreversible. Do not use if you have kidney disease, reduced kidney function or a history of kidney stones. Stay within 3.6 g/day, and stay hydrated.
- High-dose vitamin C: Your body converts vitamin C to oxalate. In one published case of acute kidney injury, the patient was taking chaga powder alongside 500 mg of vitamin C daily. Don't stack them.
- Blood thinners & surgery: A platelet-aggregation-inhibiting peptide has been isolated from chaga. Memorial Sloan Kettering advises talking to your provider before combining chaga with warfarin or similar anticoagulants, as it may increase bleeding risk. Pause it before surgery. Preclinical evidence, not proven in people - but worth respecting.
- Blood sugar & diabetes medication: Chaga terpenoids inhibit alpha-glucosidase in vitro and chaga polysaccharides lowered glucose in diabetic mice. Additive effects with metformin, sulfonylureas or insulin are plausible. Speak to your prescriber before starting.
- Pregnancy & breastfeeding: Health Canada requires a practitioner-consultation statement. There is no safety data - best avoided.
- Autoimmune conditions & immunosuppressants: Chaga's fungal polysaccharides are immunomodulating, so raise it with your prescriber first. A mechanism-based precaution, not a documented problem.
- Allergies & quality: It's a fungus - mushroom allergies can react. Chaga also concentrates what's in its environment, so buy third-party tested material and never use mouldy or poorly stored chaga.
The bottom line
Chaga is a genuinely interesting organism with a genuinely thin evidence base, and we'd rather you heard that from us than found it out later.
What's solid: it's chemically rich, it's high in antioxidant compounds, Health Canada permits calling it a source of antioxidants and a source of fungal polysaccharides with immunomodulating properties, and it has a long, well-documented history as a northern winter tonic. It's a lovely daily brew and it's very unlikely to do you harm at sensible amounts.
What's not solid: essentially every exciting claim you'll read. The antitumour, antiviral, antidiabetic and cognition findings are from cells and rodents. Memorial Sloan Kettering's summary line is unambiguous - the safety and efficacy of chaga have yet to be evaluated in clinical studies. That is not a small gap.
What genuinely requires care: the oxalate load. Heavy, long-term use of concentrated chaga powder has caused kidney damage in published cases, including irreversible kidney failure. Stay within Health Canada's 3.6 g/day ceiling, skip it entirely if you have kidney disease or stones, and don't stack it with high-dose vitamin C.
Our honest position: drink chaga because you like it and because a hot dark cup of something earthy is good for a winter morning. Don't buy it expecting it to do heavy lifting - and if a brand tells you it does, ask them for the human trial.
References
Every graded claim links to its source; here they are together.
- Antioxidant: Cui 2005, J Ethnopharmacol 96(1-2):79-85
- Immune support: Ko 2011, J Ethnopharmacol 137(3):1077-1082
- Blood sugar: Ying 2014, Phytochemistry 108:171-176; Wang 2017, PLoS One
- Stamina & resilience: Yue 2015, J Tradit Chin Med 35(4):468-472
- Skin & aging: MSK About Herbs, Chaga Mushroom
- Cancer claims: MSK About Herbs, Chaga Mushroom; Kikuchi 2014, Clin Nephrol
- NutraIngredients: USDA removes ORAC database (2012)
- MSK About Herbs, Chaga Mushroom
- Kikuchi 2014, Clin Nephrol 81(6):440-444
- MSK About Herbs, Chaga Mushroom
- Beug, NAMA Toxicology Committee; Glamoclija 2015, J Ethnopharmacol